HZNP — Horizon Therapeutics Share News
0.000.00%
HealthcareBalancedLarge Cap
- $26.63bn
- $26.72bn
- $3.63bn
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
Deals of the day-Mergers and acquisitions
Street View: Amgen has 'stronger' argument against FTC complaint
Brief: Regeneron Boss Backs Attempt To Block $28 Billion Amgen Acquisition - FT
Press Digest: New York Times business news - May 17
Brief: Moody's Says Amgen's And Horizon Therapeutics' Ratings Unaffected By FTC Recent Filing To Block The Acquisition
Drug M&A comes down with case of antitrust fever
Refinitiv Newscasts - U.S. stocks end lower after Home Depot outlook
US STOCKS-Wall Street closes lower after Home Depot outlook, US retail sales
Refinitiv Newscasts - U.S. Day Ahead: Senate Banking Committee lambasts former banking executives of Silicon Valley and Signature banks
US STOCKS-Wall Street declines after Home Depot outlook, US retail sales
US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics (updated)
US STOCKS-S&P 500, Dow fall, dragged by Home Depot outlook, US retail sales
U.S. STOCKS ON THE MOVE-Applied Digital, Amdocs, First Watch
Brief: Horizon Therapeutics Responds To U.S. Federal Trade Commission Action To Block Acquisition By Amgen
Biotech index tumbles as FTC moves to block Amgen/Horizon deal
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
U.S. STOCKS ON THE MOVE-Shake Shack, Western Alliance, Blue Apron
Brief: Amgen Responds To FTC Action On Proposed Acquisition Of Horizon Therapeutics